NEKTAR THERAPEUTICS Quarterly Share-based Payment Arrangement, Expense in USD from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Nektar Therapeutics quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q2 2010 to Q3 2024.
  • Nektar Therapeutics Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $5.39M, a 33.8% decline year-over-year.
  • Nektar Therapeutics Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $24.1M, a 38.1% decline year-over-year.
  • Nektar Therapeutics annual Share-based Payment Arrangement, Expense for 2023 was $33.4M, a 41.8% decline from 2022.
  • Nektar Therapeutics annual Share-based Payment Arrangement, Expense for 2022 was $57.3M, a 39.5% decline from 2021.
  • Nektar Therapeutics annual Share-based Payment Arrangement, Expense for 2021 was $94.7M, a 0.44% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $24.1M $5.39M -$2.76M -33.8% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-08
Q2 2024 $26.8M $5.42M -$2.55M -32% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-09
Q1 2024 $29.4M $6M -$4.02M -40.1% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-10
Q4 2023 $33.4M $7.25M -$5.48M -43.1% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-05
Q3 2023 $38.9M $8.15M -$4.37M -34.9% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-08
Q2 2023 $43.2M $7.97M -$3.14M -28.3% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-09
Q1 2023 $46.4M $10M -$10.9M -52.2% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-10
Q4 2022 $57.3M $12.7M -$9.67M -43.1% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-05
Q3 2022 $67M $12.5M -$12.1M -49.2% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 $79.1M $11.1M -$12.6M -53.2% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 $91.7M $21M -$2.94M -12.3% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q4 2021 $94.7M $22.4M +$418K +1.9% Oct 1, 2021 Dec 31, 2021 10-K 2024-03-05
Q3 2021 $94.3M $24.7M +$990K +4.18% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-04
Q2 2021 $93.3M $23.7M +$343K +1.47% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-05
Q1 2021 $92.9M $23.9M -$1.34M -5.3% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-06
Q4 2020 $94.3M $22M -$3.02M -12.1% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-28
Q3 2020 $97.3M $23.7M -$1.21M -4.88% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-05
Q2 2020 $98.5M $23.4M -$1.15M -4.69% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-06
Q1 2020 $99.6M $25.2M -$149K -0.59% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-07
Q4 2019 $99.8M $25M +$802K +3.31% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-01
Q3 2019 $99M $24.9M +$1.59M +6.84% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-06
Q2 2019 $97.4M $24.5M +$3.86M +18.7% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-07
Q1 2019 $93.5M $25.4M +$5.44M +27.2% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-08
Q4 2018 $88.1M $24.2M +$12.7M +111% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-26
Q3 2018 $75.4M $23.3M +$14.5M +164% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-07
Q2 2018 $60.9M $20.7M +$12.6M +155% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-09
Q1 2018 $48.4M $19.9M +$11.8M +144% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
Q4 2017 $36.6M $11.5M +$4.44M +62.9% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-28
Q3 2017 $32.2M $8.84M +$2.67M +43.3% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-08
Q2 2017 $29.5M $8.1M +$1.84M +29.3% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 $27.7M $8.18M +$1.82M +28.6% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q4 2016 $25.9M $7.06M +$1.89M +36.5% Oct 1, 2016 Dec 31, 2016 10-K 2019-03-01
Q3 2016 $24M $6.17M +$1.4M +29.5% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-08
Q2 2016 $22.6M $6.26M +$1.7M +37.4% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-09
Q1 2016 $20.9M $6.36M +$1.19M +22.9% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-10
Q4 2015 $19.7M $5.17M +$800K +18.3% Oct 1, 2015 Dec 31, 2015 10-K 2018-03-01
Q3 2015 $18.9M $4.76M +$640K +15.5% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-04
Q2 2015 $18.2M $4.56M +$396K +9.51% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-04
Q1 2015 $17.8M $5.18M +$816K +18.7% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-04
Q4 2014 $17M $4.37M -$173K -3.81% Oct 1, 2014 Dec 31, 2014 10-K 2017-03-01
Q3 2014 $17.2M $4.12M -$442K -9.68% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-06
Q2 2014 $17.6M $4.16M -$192K -4.41% Apr 1, 2014 Jun 30, 2014 10-Q 2014-08-01
Q1 2014 $17.8M $4.36M +$116K +2.73% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-01
Q4 2013 $17.7M $4.54M +$359K +8.58% Oct 1, 2013 Dec 31, 2013 10-K 2016-03-01
Q3 2013 $17.3M $4.56M +$584K +14.7% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-07
Q2 2013 $16.8M $4.36M +$555K +14.6% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-01
Q1 2013 $16.2M $4.25M +$11K +0.26% Jan 1, 2013 Mar 31, 2013 10-Q 2013-05-09
Q4 2012 $16.2M $4.18M -$200K -4.56% Oct 1, 2012 Dec 31, 2012 10-K 2015-02-26
Q3 2012 $16.4M $3.98M -$839K -17.4% Jul 1, 2012 Sep 30, 2012 10-Q 2012-11-09
Q2 2012 $17.2M $3.8M -$1.08M -22.1% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-09
Q1 2012 $18.3M $4.23M -$568K -11.8% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-09
Q4 2011 $18.9M $4.38M Oct 1, 2011 Dec 31, 2011 10-K 2013-03-01
Q3 2011 $4.82M +$208K +4.51% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-09
Q2 2011 $4.88M +$519K +11.9% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-09
Q1 2011 $4.8M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-04
Q3 2010 $4.61M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-04
Q2 2010 $4.36M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.